Free Account Opening + AMC Free Demat
Loading...

Medplus Health IPO vs Metro Brands IPO

Comparision between Medplus Health IPO and Metro Brands IPO.

IPO Details

Medplus Health IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Metro Brands IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Medplus Health IPO is up to ₹1,398.30 Cr whereas the issue size of the Metro Brands IPO is up to ₹1,367.51 Cr. The final issue price of Medplus Health IPO is ₹796.00 per share and of Metro Brands IPO is ₹500.00 per share.

  Medplus Health IPO Metro Brands IPO
Face Value ₹2 per share ₹5 per share
Issue Price (Lower) ₹780.00 per share ₹485.00 per share
Issue Price (Upper) ₹796.00 per share ₹500.00 per share
Issue Price (Final) ₹796.00 per share ₹500.00 per share
Discount (Retail)
Discount (Employee) ₹78.00 per share
Market Lot Size 18 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹600.00 Cr up to ₹295.00 Cr
OFS Issue Size 2,14,50,100 shares
OFS Issue Size (Amount) up to ₹798.30 Cr up to ₹1,072.51 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,398.30 Cr up to ₹1,367.51 Cr

IPO Timetable

Medplus Health IPO opens on Dec 13, 2021, while Metro Brands IPO opens on Dec 10, 2021. The closing date of Medplus Health IPO and Metro Brands IPO is Dec 15, 2021, and Dec 14, 2021, respectively.

  Medplus Health IPO Metro Brands IPO
Anchor Bid Date
Issue Open Dec 13, 2021 Dec 10, 2021
Issue Close Dec 15, 2021 Dec 14, 2021
Basis Of Allotment (Tentative) Dec 20, 2021 Dec 17, 2021
Initiation of Refunds (Tentative) Dec 21, 2021 Dec 20, 2021
Credit of Share (Tentative) Dec 22, 2021 Dec 21, 2021
Listing date (Tentative) Dec 23, 2021 Dec 22, 2021
Anchor Lockin End date 1 Jan 19, 2022 Jan 16, 2022
Anchor Lockin End date 2 Mar 20, 2022 Mar 17, 2022

Financials

Medplus Health IPO P/E ratio is , as compared to Metro Brands IPO P/E ratio of .

  Medplus Health IPO Metro Brands IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 17,464.94 15,656.58 13,486.96 9,587.11
Total Revenue 18,908.99 30,908.14 28,878.87 22,849.40
Profit After Tax 663.67 631.11 17.94 119.22
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 17,396.06 16,593.40 16,174.23 13,215.06
Total Revenue 4,892.68 8,785.38 13,110.68 12,368.95
Profit After Tax 430.74 646.19 1,605.75 1,527.31
Promoter Shareholding (Pre-Issue) 43.16% 84.02%
Promoter Shareholding (Post-Issue) 40.43% 74.27%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Medplus Health IPO retail investors (RII) are offered 62,51,965 shares while in Metro Brands IPO retail investors are offered 62,51,965 shares. Qualified institutional buyers (QIB) are offered 35,72,550 shares in Medplus Health IPO and 54,70,020 shares in Metro Brands IPO.

  Medplus Health IPO Metro Brands IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 35,72,550 shares 54,70,020 shares
NII 26,79,414 shares 41,02,515 shares
RII 62,51,965 shares 95,72,535 shares
Employee 71,225 shares 0 shares
Others
Total 1,25,75,154 shares 1,91,45,070 shares

Bids Received (Subscription)

Medplus Health IPO subscribed 52.59x in total, whereas Metro Brands IPO subscribed 3.64x.

  Medplus Health IPO Metro Brands IPO
QIB (times) 111.90x 8.49x
NII (times) 85.33x 3.02x
Big NII (times)
Small NII (times)
RII (times) 5.24x 1.13x
Employee (times) 3.05x
Other (times)
Total (times) 52.59x 3.64x

Comments

Add a public comment...